Jonathan Chauvin

Relation between Plasma Trough Concentration of Pazopanib and Progression-Free Survival in Metastatic Soft Tissue Sarcoma Patients

F. Goldwasser, C. Tlemsani, A. Jouinot, 2022, Pharmaceutics.

Adaptive dosing of sunitinib in a metastatic renal cell carcinoma patient: when in silico modeling helps to go quicker to the point

J. Ciccolini, J. Deville, Jonathan Chauvin, 2022, Cancer Chemotherapy and Pharmacology.

Efficient Pharmacokinetic Modeling Workflow With the MonolixSuite: A Case Study of Remifentanil

Jonathan Chauvin, Pauline Traynard, Monika Twarogowska, 2020, CPT: pharmacometrics & systems pharmacology.

Estradiol Regulates mRNA Levels of Estrogen Receptor Beta 4 and Beta 5 Isoforms and Modulates Human Granulosa Cell Apoptosis

N. Frydman, M. Grynberg, J. Cohen‐Tannoudji, 2021, International journal of molecular sciences.

A novel method based on unbiased correlations tests for covariate selection in nonlinear mixed effects models: The COSSAC approach

Jonathan Chauvin, Géraldine Ayral, Jean-François Si Abdallah, 2021, CPT: pharmacometrics & systems pharmacology.

Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care.

R. Flippot, C. Joly, A. Jouinot, 2024, British journal of cancer.